Ionis Pharmaceuticals Revenue 2006-2019 | IONS

Ionis Pharmaceuticals annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Ionis Pharmaceuticals revenue for the quarter ending September 30, 2019 was $0.168B, a 15.47% increase year-over-year.
  • Ionis Pharmaceuticals revenue for the twelve months ending September 30, 2019 was $0.821B, a 42.7% increase year-over-year.
  • Ionis Pharmaceuticals annual revenue for 2018 was $0.6B, a 16.63% increase from 2017.
  • Ionis Pharmaceuticals annual revenue for 2017 was $0.514B, a 37.93% increase from 2016.
  • Ionis Pharmaceuticals annual revenue for 2016 was $0.373B, a 31.4% increase from 2015.
Ionis Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $600
2017 $514
2016 $373
2015 $284
2014 $214
2013 $147
2012 $102
2011 $99
2010 $108
2009 $122
2008 $107
2007 $58
2006 $15
2005 $40
Ionis Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $168
Q2 2019 $164
Q1 2019 $297
Q4 2018 $192
Q3 2018 $145
Q2 2018 $118
Q1 2018 $144
Q4 2017 $168
Q3 2017 $118
Q2 2017 $112
Q1 2017 $116
Q4 2016 $187
Q3 2016 $111
Q2 2016 $38
Q1 2016 $37
Q4 2015 $52
Q3 2015 $49
Q2 2015 $120
Q1 2015 $63
Q4 2014 $85
Q3 2014 $44
Q2 2014 $57
Q1 2014 $28
Q4 2013 $42
Q3 2013 $24
Q2 2013 $38
Q1 2013 $43
Q4 2012 $20
Q3 2012 $12
Q2 2012 $47
Q1 2012 $23
Q4 2011 $32
Q3 2011 $21
Q2 2011 $25
Q1 2011 $21
Q4 2010 $26
Q3 2010 $29
Q2 2010 $24
Q1 2010 $30
Q4 2009 $32
Q3 2009 $27
Q2 2009 $31
Q1 2009 $32
Q4 2008 $30
Q3 2008 $29
Q2 2008 $30
Q1 2008 $18
Q4 2007 $13
Q3 2007 $39
Q2 2007 $4
Q1 2007 $2
Q4 2006 $2
Q3 2006 $3
Q2 2006 $4
Q1 2006 $5
Q4 2005 $15
Q3 2005 $7
Q2 2005 $11
Q1 2005 $7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.128B $0.600B
Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $64.338B 10.17
Zoetis (ZTS) United States $56.584B 33.85
Astellas Pharma (ALPMY) Japan $31.772B 15.87
Eisai (ESALY) Japan $19.681B 37.95
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.373B 20.98
Grifols, S.A (GRFS) Spain $15.202B 19.40
Neurocrine Biosciences (NBIX) United States $10.558B 498.43
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.043B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.842B 10.02
Sage Therapeutics (SAGE) United States $7.563B 0.00
Catalent (CTLT) United States $7.377B 30.01
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.001B 17.98
Arrowhead Pharmaceuticals (ARWR) United States $4.567B 104.72
United Therapeutics (UTHR) United States $3.978B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.517B 12.85
FibroGen (FGEN) United States $3.217B 94.54
Nektar Therapeutics (NKTR) United States $3.168B 0.00
Evotec AG (EVTCY) Germany $3.081B 50.42
PTC Therapeutics (PTCT) United States $2.732B 0.00
Portola Pharmaceuticals (PTLA) United States $2.183B 0.00
Xencor (XNCR) United States $2.058B 62.57
Heron Therapeutics (HRTX) United States $2.019B 0.00
Tilray (TLRY) Canada $1.996B 0.00
Zogenix (ZGNX) United States $1.991B 0.00
Corcept Therapeutics (CORT) United States $1.921B 23.35
Pacira Pharmaceuticals (PCRX) United States $1.797B 53.17
Ironwood Pharmaceuticals (IRWD) United States $1.796B 57.25
USANA Health Sciences (USNA) United States $1.555B 16.59
Enanta Pharmaceuticals (ENTA) United States $1.247B 20.57
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.140B 0.00
Endo (ENDP) Ireland $1.010B 1.86
Theravance Biopharma (TBPH) Cayman Islands $0.983B 0.00
Karyopharm Therapeutics (KPTI) United States $0.969B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.940B 0.00
ArQule (ARQL) United States $0.916B 0.00
Aerie Pharmaceuticals (AERI) United States $0.881B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.846B 5.78
Organogenesis Holdings (ORGO) United States $0.738B 0.00
TherapeuticsMD (TXMD) United States $0.713B 0.00
Collegium Pharmaceutical (COLL) United States $0.632B 0.00
Flexion Therapeutics (FLXN) United States $0.615B 0.00
Translate Bio (TBIO) United States $0.578B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.542B 0.00
ChemoCentryx (CCXI) United States $0.505B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.468B 56.75
Aptorum Group (APM) Hong Kong, SAR China $0.461B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.440B 0.00
OptiNose (OPTN) United States $0.422B 0.00
Dermira (DERM) United States $0.420B 0.00
Siga Technologies (SIGA) United States $0.417B 9.52
Ardelyx (ARDX) United States $0.404B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.391B 16.87
Recro Pharma (REPH) United States $0.378B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
Akebia Therapeutics (AKBA) United States $0.376B 0.00
Indivior (INVVY) United States $0.367B 1.33
Lannett Co Inc (LCI) United States $0.364B 4.24
DURECT (DRRX) United States $0.364B 0.00
Innate Pharma SA (IPHYF) France $0.340B 0.00
Harpoon Therapeutics (HARP) United States $0.340B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.283B 0.00
Molecular Templates (MTEM) United States $0.267B 0.00
Rafael Holdings (RFL) United States $0.252B 0.00
GlycoMimetics (GLYC) United States $0.248B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.213B 0.00
Xeris Pharmaceuticals (XERS) United States $0.212B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.202B 0.00
KalVista Pharmaceuticals (KALV) United States $0.199B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.189B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.188B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 32.17
Calithera Biosciences (CALA) United States $0.182B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 2.27
Concert Pharmaceuticals (CNCE) United States $0.163B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.161B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.140B 0.00
Aquestive Therapeutics (AQST) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
MEI Pharma (MEIP) United States $0.133B 0.00
Ocular Therapeutix (OCUL) United States $0.132B 0.00
CV Sciences (CVSI) United States $0.127B 0.00
IMV INC (IMV) Canada $0.124B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.123B 0.00
Cardiome Pharma (CORV) Canada $0.113B 0.00
CannTrust Holdings (CTST) Canada $0.113B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.101B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.094B 0.00
Majesco Entertainment (PTE) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.075B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Otonomy (OTIC) United States $0.073B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.071B 21.30
Pharmaxis (PXSLY) Australia $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Generex Biotechnology (GNBT) United States $0.064B 0.00
Champions Oncology (CSBR) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.058B 14.55
Genocea Biosciences (GNCA) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.053B 0.00
Novan (NOVN) United States $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Nivalis Therapeutics (ALPN) United States $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Bio-Path Holdings (BPTH) United States $0.029B 0.00
IsoRay (ISR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00